The University of Chicago Header Logo

Connection

Anita S. Chong to B-Lymphocytes

This is a "connection" page, showing publications Anita S. Chong has written about B-Lymphocytes.
Connection Strength

9.165
  1. Beyond Adaptive Alloreactivity: Contribution of Innate B Cells to Allograft Inflammation and Rejection. Transplantation. 2023 01 01; 107(1):98-104.
    View in: PubMed
    Score: 0.627
  2. Pregnancy-induced humoral sensitization overrides T cell tolerance to fetus-matched allografts in mice. J Clin Invest. 2021 01 04; 131(1).
    View in: PubMed
    Score: 0.550
  3. Transplantation tolerance modifies donor-specific B cell fate to suppress de novo alloreactive B cells. J Clin Invest. 2020 07 01; 130(7):3453-3466.
    View in: PubMed
    Score: 0.531
  4. B cells as antigen-presenting cells in transplantation rejection and tolerance. Cell Immunol. 2020 03; 349:104061.
    View in: PubMed
    Score: 0.517
  5. Outstanding questions in transplantation: B cells, alloantibodies, and humoral rejection. Am J Transplant. 2019 08; 19(8):2155-2163.
    View in: PubMed
    Score: 0.488
  6. Heterogeneity of memory B cells. Am J Transplant. 2018 04; 18(4):779-784.
    View in: PubMed
    Score: 0.450
  7. Evolving Approaches in the Identification of Allograft-Reactive T and B Cells in Mice and Humans. Transplantation. 2017 11; 101(11):2671-2681.
    View in: PubMed
    Score: 0.442
  8. Alone Again, Naturally: B Cells Encountering Antigen Without T cells. Transplantation. 2017 09; 101(9):1956-1958.
    View in: PubMed
    Score: 0.437
  9. Tracing Donor-MHC Class II Reactive B cells in Mouse Cardiac Transplantation: Delayed CTLA4-Ig Treatment Prevents Memory Alloreactive B-Cell Generation. Transplantation. 2016 08; 100(8):1683-91.
    View in: PubMed
    Score: 0.405
  10. Delayed Cytotoxic T Lymphocyte-Associated Protein 4-Immunoglobulin Treatment Reverses Ongoing Alloantibody Responses and Rescues Allografts From Acute Rejection. Am J Transplant. 2016 08; 16(8):2312-23.
    View in: PubMed
    Score: 0.396
  11. Cutting Edge: CTLA-4Ig Inhibits Memory B Cell Responses and Promotes Allograft Survival in Sensitized Recipients. J Immunol. 2015 Nov 01; 195(9):4069-73.
    View in: PubMed
    Score: 0.382
  12. Memory B cells in transplantation. Transplantation. 2015 Jan; 99(1):21-8.
    View in: PubMed
    Score: 0.363
  13. Reversing endogenous alloreactive B cell GC responses with anti-CD154 or CTLA-4Ig. Am J Transplant. 2013 Sep; 13(9):2280-92.
    View in: PubMed
    Score: 0.328
  14. "Tip-toeing" to an assay for transplantation tolerance? Am J Transplant. 2012 Mar; 12(3):519-20.
    View in: PubMed
    Score: 0.293
  15. Matchmaking the B-cell signature of tolerance to regulatory B cells. Am J Transplant. 2011 Dec; 11(12):2555-60.
    View in: PubMed
    Score: 0.290
  16. Experimental models of B cell tolerance in transplantation. Semin Immunol. 2012 Apr; 24(2):77-85.
    View in: PubMed
    Score: 0.289
  17. Making a B-line for transplantation tolerance. Am J Transplant. 2011 Mar; 11(3):420-1.
    View in: PubMed
    Score: 0.277
  18. Long-term control of alloreactive B cell responses by the suppression of T cell help. J Immunol. 2008 May 01; 180(9):6077-84.
    View in: PubMed
    Score: 0.229
  19. Peripheral deletion of mature alloreactive B cells induced by costimulation blockade. Proc Natl Acad Sci U S A. 2007 Jul 17; 104(29):12093-8.
    View in: PubMed
    Score: 0.216
  20. Intact active bone transplantation synergizes with anti-CD40 ligand therapy to induce B cell tolerance. J Immunol. 2002 May 15; 168(10):5352-8.
    View in: PubMed
    Score: 0.151
  21. Innate-like self-reactive B cells infiltrate human renal allografts during transplant rejection. Nat Commun. 2021 07 16; 12(1):4372.
    View in: PubMed
    Score: 0.143
  22. Mechanisms of organ transplant injury mediated by B cells and antibodies: Implications for antibody-mediated rejection. Am J Transplant. 2020 06; 20 Suppl 4:23-32.
    View in: PubMed
    Score: 0.132
  23. B Cell Recruitment Follows Kidney Injury and Maladaptive Repair. Transplantation. 2019 08; 103(8):1527-1529.
    View in: PubMed
    Score: 0.125
  24. New insights into the development of B cell responses: Implications for solid organ transplantation. Hum Immunol. 2019 Jun; 80(6):378-384.
    View in: PubMed
    Score: 0.117
  25. Self-Antigen-Driven Thymic B Cell Class Switching Promotes T Cell Central Tolerance. Cell Rep. 2016 10 04; 17(2):387-398.
    View in: PubMed
    Score: 0.102
  26. Immune complex formation and in situ B-cell clonal expansion in human cerebral cavernous malformations. J Neuroimmunol. 2014 Jul 15; 272(1-2):67-75.
    View in: PubMed
    Score: 0.087
  27. Impact of immunosuppression on recall immune responses to influenza vaccination in stable renal transplant recipients. Transplantation. 2014 Apr 27; 97(8):846-53.
    View in: PubMed
    Score: 0.087
  28. AST Cutting Edge of Transplantation 2013 Meeting Report: a comprehensive look at B cells and antibodies in transplantation. Am J Transplant. 2014 Mar; 14(3):524-30.
    View in: PubMed
    Score: 0.085
  29. Lessons and limits of mouse models. Cold Spring Harb Perspect Med. 2013 Dec 01; 3(12):a015495.
    View in: PubMed
    Score: 0.084
  30. The use of self-adjuvanting nanofiber vaccines to elicit high-affinity B cell responses to peptide antigens without inflammation. Biomaterials. 2013 Nov; 34(34):8776-85.
    View in: PubMed
    Score: 0.082
  31. B cells assist allograft rejection in the deficiency of protein kinase c-theta. Transpl Int. 2013 Sep; 26(9):919-27.
    View in: PubMed
    Score: 0.082
  32. Transcriptional regulation of germinal center B and plasma cell fates by dynamical control of IRF4. Immunity. 2013 May 23; 38(5):918-29.
    View in: PubMed
    Score: 0.081
  33. Plasma cell densities and glomerular filtration rates predict renal allograft outcomes following acute rejection. Transpl Int. 2012 Oct; 25(10):1050-8.
    View in: PubMed
    Score: 0.077
  34. American society of transplantation symposium on B cells in transplantation: harnessing humoral immunity from rodent models to clinical practice. Am J Transplant. 2007 Jun; 7(6):1464-70.
    View in: PubMed
    Score: 0.054
  35. Transcriptionally Distinct B Cells Infiltrate Allografts After Kidney Transplantation. Transplantation. 2023 02 01; 107(2):e47-e57.
    View in: PubMed
    Score: 0.039
  36. Development and characterization of anti-Gal B cell receptor transgenic Gal-/- mice. Transplantation. 2002 May 27; 73(10):1549-57.
    View in: PubMed
    Score: 0.038
  37. Inhibition of JAK3 and STAT6 tyrosine phosphorylation by the immunosuppressive drug leflunomide leads to a block in IgG1 production. J Immunol. 1998 Feb 15; 160(4):1581-8.
    View in: PubMed
    Score: 0.028
  38. Active immunotherapy for TNF-mediated inflammation using self-assembled peptide nanofibers. Biomaterials. 2017 Dec; 149:1-11.
    View in: PubMed
    Score: 0.027
  39. Regulation of B cell function by the immunosuppressive agent leflunomide. Transplantation. 1996 Feb 27; 61(4):635-42.
    View in: PubMed
    Score: 0.025
  40. Mouse-heart grafts expressing an incompatible carbohydrate antigen. II. Transition from accommodation to tolerance. Transplantation. 2004 Feb 15; 77(3):366-73.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.